Meganck, Rita M. http://orcid.org/0000-0003-2799-3754
Baric, Ralph S. http://orcid.org/0000-0001-6827-8701
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI108197, AI132178, AI157155)
Article History
Received: 25 January 2021
Accepted: 8 February 2021
First Online: 15 March 2021
Competing interests
: R.S.B. has competing interests regarding collaborative research with Gilead Sciences, Ridgeback Biotherapeutics, Takeda, Pfizer, Eli Lily, Adimab and Moderna Therapeutics.
Free to read: This content has been made available to all.